Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Refining the Roadmap: Practical Insights on the 2026 AUA/SUO Advanced Prostate Cancer Amendment.
Journal: The Journal of urology
Published: September 03, 2026
SWI/SNF Alterations Define a Chromatin-Dependent Subtype of Urothelial Carcinoma.
Journal: bioRxiv : the preprint server for biology
Published: August 20, 2026
Insulin Pathway Changes in Localized Prostate Cancer: A Multi-Institutional Analysis.
Journal: Cancers
Published: March 28, 2026
Clinical and Genomic Features of Androgen Indifferent Prostate Cancer.
Journal: International journal of molecular sciences
Published: December 12, 2024
When You Get to the Fork in the Road, Take It: The Challenges in Managing Patients With Advanced Prostate Cancer.
Journal: JCO oncology practice
Published: October 01, 2024
Impact of DPP4 Inhibition on Survival in Patients With Metastatic Renal Cell Carcinoma and Type 2 Diabetes Mellitus.
Journal: Clinical genitourinary cancer
Published: July 03, 2024
Impact of Renin-Angiotensin System Inhibitors on Response to PD1/L1 Inhibitors in Patients With Metastatic Renal Cell Carcinoma.
Journal: Clinical genitourinary cancer
Published: July 03, 2024
Clinical Management of Advanced Prostate Cancer: Where Does Radiopharmaceutical Therapy Fit in the Treatment Algorithm?
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: January 09, 2024
A Modular Trial of Androgen Signaling Inhibitor Combinations Testing a Risk-Adapted Strategy in Patients with Metastatic Castration-Resistant Prostate Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 05, 2023
Evaluation of the Aggressive-Variant Prostate Cancer Molecular Signature in Clinical Laboratory Improvement Amendments (CLIA) Environments.
Journal: Cancers
Published: November 06, 2023
Treatment Outcomes in Patients With Metastatic Renal Cell Carcinoma With Sarcomatoid and/or Rhabdoid Dedifferentiation After Progression on Immune Checkpoint Therapy.
Journal: The oncologist
Published: August 14, 2023
Last Updated: 09/26/2026